Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-012630
Filing Date
2022-05-05
Accepted
2022-05-05 16:06:34
Documents
76
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ardx-20220331.htm   iXBRL 10-Q 1571174
2 EX-10.1 slrloanandsecurityagreemen.htm EX-10.1 594322
3 EX-10.2 slrexitfeeagreement-ex102.htm EX-10.2 34970
4 EX-31.1 ardx-20220331xex311.htm EX-31.1 9855
5 EX-31.2 ardx-20220331xex312.htm EX-31.2 9860
6 EX-32.1 ardx-20220331xex321.htm EX-32.1 6520
12 ardx-20220331_g1.jpg GRAPHIC 75659
  Complete submission text file 0001628280-22-012630.txt   7812106

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20220331.xsd EX-101.SCH 50043
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ardx-20220331_cal.xml EX-101.CAL 63274
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ardx-20220331_def.xml EX-101.DEF 232617
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20220331_lab.xml EX-101.LAB 614892
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20220331_pre.xml EX-101.PRE 398523
70 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20220331_htm.xml XML 1033237
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36485 | Film No.: 22896187
SIC: 2834 Pharmaceutical Preparations